FABIO D G
FABIO DE GREGORIO, Vice President, Head of Drug Safety Europe, Shionogi Europe
• Dr De Gregorio serves as Vice President and Head of Drug Safety at Shionogi Europe, where he leads the European Pharmacovigilance Team.
• He has 25-year experience in the pharma industry in various roles, functions, and therapeutic areas.
• He has worked in pharmacovigilance since 2004 and spent more than 12 years as a QPPV.
• Among his achievements, he successfully set up the pharmacovigilance system of several small medium enterprises, and from the clinical development perspective, he received international awards for his researches on an innovative treatment for ocular hypotony.
• Dr De Gregorio graduated in Medicine from “La Sapienza” University of Rome, Italy, specialised in ophthalmology, which practised for over 20 years and has also a PhD in pathophysiology of ocular circulation.